Method for preparing amyloid protein fiber by using low-temperature plasma

The aqueous protein solution is processed under neutral conditions through low-temperature plasma technology, and high-energy active particles are used to promote the formation of protein fibers, solving the problems of protein denaturation and complex processes in acid-heat method, and achieving efficient and stable preparation of protein fibers.

CN118901862APending Publication Date: 2024-11-08HUNAN AGRI UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410898657.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing acid-heat method for preparing protein fibers in a highly acidic environment has problems of protein denaturation and inactivation, and the process is complicated and the preparation efficiency is low.

Method used

Low-temperature plasma technology is used to treat the aqueous protein solution under neutral conditions of pH 3-7, and high-energy active particles are generated using a medium-barrier discharge plasma device to promote the formation of protein fibers, combining water bath heating and freeze-drying steps.

Benefits of technology

Effectively protect protein structure and activity, shorten the time of protein fiber formation, improve product quality stability, simplify the process, and avoid chemical residues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118901862A_ABST
    Figure CN118901862A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of food processing, and discloses a method for preparing amyloid protein fiber by low-temperature plasma, which comprises the following steps: step 1, weighing protein powder, dispersing the protein powder in deionized water, and stirring to fully disperse the protein powder to obtain a protein aqueous solution; step 2, processing the protein aqueous solution prepared in the step 1 by dielectric barrier discharge plasma equipment; 3, carrying out water bath heating treatment on the protein aqueous solution treated in the step 2, and immediately carrying out ice-water bath to terminate the reaction after the heating is finished; and 4, freeze-drying to obtain the amyloid protein fibril. According to the method, additional acid adjustment is not needed, the limitation of a high-acidity environment and long time of a traditional acid heating method for preparing the amyloid protein fiber is broken through, and the method for rapidly and efficiently preparing the amyloid protein fiber is provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of food processing, in particular to a method for preparing amyloid protein fibers using low-temperature plasma. Background Art

[0002] Protein fibrillation aggregation is a process in which proteins denature and hydrolyze under acid-heat (pH=2.0, 80-90℃) conditions and self-assemble perpendicular to the fiber axis to form fiber aggregates based on cross-β-folding. Protein fibers have attracted much attention because of their extremely high aspect ratio, good molecular flexibility and abundant surface functional groups, which enable them to obtain excellent functional properties. At present, the typical acid-heat protein fibrillation process includes: lag phase, growth phase and maturity phase. It contains two processes: primary nucleation, i.e. the formation of homogeneous nuclei (lag phase) and secondary nucleation, i.e. the formation of mature fibers (growth phase and maturity phase). Among them, the lag phase is the rate-limiting stage of protein fiber formation. In this stage, ① protein hydrolysis: protein hydrolysis releases polypeptides (building the basic unit of protein fibers), especially the β-folding structure located inside the protein molecule; ② homogeneous nucleus formation: polypeptides initially aggregate under hydrophobic and electrostatic interaction forces to form homogeneous nuclei, which are the two key points that determine the efficiency of protein fibrillation. Since protein hydrolysis releases polypeptides, the formation of a large number of building blocks (β-folded structure) is a prerequisite for nucleation, and the nucleation energy barrier is high, which leads to the problems of high acidic environment, long reaction time and low preparation efficiency in the traditional acid-heat protein fibrillation. In order to overcome these problems, the means currently relied on mainly include nuclear induction, enzyme hydrolysis and physical field synergy. Among the above-mentioned technical means to promote protein fibrillation aggregation, the methods of nuclear induction and physical field synergy can effectively promote protein fibrillation to a certain extent, but they are still based on the acid-heat method. Enzyme hydrolysis can break through the high acidity and long-term heating conditions of the traditional acid-heat method, but the specificity of the enzyme hydrolysis site means that only trypsin currently shows good results, and enzyme hydrolysis has problems such as high cost and complex process.

[0003] Cold plasma technology (CP) is a new physical method that uses high-energy reactive oxygen and nitrogen particles (RONS) to modify the physical properties of the matrix. It has unique advantages in the field of food processing, especially in protein modification, because of its green, non-thermal, and chemical residue-free characteristics. As a new non-thermal physical processing method, CP is a complex physical and chemical reaction of gas under the coupling of multiple fields such as high-energy electromagnetic fields, which produces active particles with different lifespans (·OH, O, O3, NxOy, H2O2, etc.). The mediated oxidation effect acts on the food matrix to achieve food sterilization and preservation and macromolecular structure modification. Previous studies have shown that compared with the acid-heat method, CP assisted by heating (no acid adjustment) has the effect of greatly shortening the aggregation lag phase of protein fibrillation and accelerating the formation of protein fibers. The possible mechanism of accelerating protein fibrillation is that CP breaks the peptide chain and promotes the formation of homogeneous nuclei. In general, CP acts on proteins, which has the effect of breaking the protein peptide chain similar to enzymatic hydrolysis to generate small molecule peptides, and the CP breaking site has a certain specificity, but it is not restricted by the site like enzymatic hydrolysis. Therefore, CP can not only break through the limitations of the traditional acid-heat method based on general physical fields in inducing protein fibrillation, but also has the advantages of enzymatic hydrolysis, but is more broad-spectrum than enzymatic hydrolysis.

[0004] The existing method for preparing amyloid protein fibers uses the acid-heat method, which requires fiber-forming conditions in a highly acidic environment of pH = 2. This method will cause partial denaturation and inactivation of proteins in a highly acidic environment, affecting the structure and properties of the fibers. Secondly, it is necessary to precisely control the acidic conditions, temperature and time, and the process is highly complex, which can easily affect the stability and scalability of production.

[0005] To this end, we proposed a method for preparing amyloid protein fibers using low-temperature plasma to solve the above technical problems. Summary of the invention

[0006] 1. Technical issues to be resolved

[0007] In view of the shortcomings of the prior art, the present invention provides a method for preparing amyloid protein fibers using low-temperature plasma, which breaks through the fiber-forming conditions of the existing acid-heat method in a highly acidic environment of pH = 2. The method forms protein fibers under neutral conditions of pH 3-7, solving the problem that the prior art may cause partial denaturation and inactivation of proteins in a highly acidic environment.

[0008] (II) Technical solution

[0009] In order to achieve the purpose of forming protein fibers under the above-mentioned neutral conditions, the present invention provides the following technical solution, comprising the following steps:

[0010] Step 1, weighing protein powder, dispersing it in deionized water, and stirring to fully disperse it to obtain a protein aqueous solution;

[0011] Step 2, treating the protein aqueous solution obtained in step 1 by a dielectric barrier discharge plasma device;

[0012] Step 3, heating the protein aqueous solution after the treatment in step 2 in a water bath, and immediately placing it in an ice water bath after the heating is completed to terminate the reaction;

[0013] Step 4: freeze-drying to obtain amyloid fibrils.

[0014] Preferably, the protein powder in step 1 is one or more of ovalbumin, pea protein isolate, whey protein, β-lactoglobulin and soy protein isolate.

[0015] Preferably, the concentration of the protein aqueous solution in step 1 is 2 to 100 mg / mL.

[0016] Preferably, in the step 1, the stirring speed is 30 to 1600 rpm, and the hydration time of the protein aqueous solution is 1 to 300 min.

[0017] Preferably, the dielectric barrier discharge plasma equipment in step 2 is composed of a plasma power supply system, a transformer, a processing system and a sample container. The processing voltage of the plasma power supply system is 10 to 50 kV and the frequency is 0.5 to 5 kHz. The processing system uses a quartz plate as an insulating medium, the distance between electrodes is 0 to 10 mm, the sample container is a quartz dish, and the working gas of the dielectric barrier discharge plasma equipment is one or more of air, nitrogen, argon or helium. The processing process is: a certain amount of sample is placed in the quartz dish, the distance between the two electrodes is adjusted to 8 mm, the insulating medium plate is fixed to the upper electrode, and air is used as the ionization medium.

[0018] Preferably, the parameters of the quartz dish are φ40-60 mm and the height is 3-8 mm.

[0019] Preferably, the dielectric barrier discharge plasma equipment treatment time in step 2 is 0 to 20 minutes.

[0020] Preferably, the temperature of the water bath heating treatment in step three is 50-100°C.

[0021] Preferably, the time of water bath heating treatment in step 3 is 0 to 72 hours.

[0022] Preferably, the freeze-drying time in step 4 is 8 to 72 hours.

[0023] Compared with the prior art, the present invention provides a method for preparing amyloid protein fibers using low-temperature plasma, which has the following beneficial effects:

[0024] 1. The traditional acid-heat method is to hydrolyze the protein into polypeptides under the addition of acid (pH=2) and heat (above 85°C), and then the polypeptides self-organize to form protein fibers. This method uses low-temperature plasma (CP) to ionize working gases (air, nitrogen, helium, etc.) under the action of high-intensity electric fields to produce various high-energy active particles, such as atomic oxygen (O or ·O-), hydroxyl radicals (·OH), peroxides (O2- or H2O2), ozone (O3), nitric oxide (NO), etc. The bombardment and oxidation effects produced cause the peptide chains to break and produce polypeptides, thus breaking through the fiber-forming conditions of the existing acid-heat method under highly acidic environments. This method forms protein fibers under pH=3-7 or even neutral conditions. The advantage of this is that it can effectively protect the structure and activity of the protein and avoid denaturation or inactivation caused by a highly acidic environment. It is suitable for more types of proteins because it does not rely on acidic conditions and can be operated in a wider pH range to form fibers under more controllable conditions, which helps to stably and consistently control the fiber formation process, thereby improving the stability of product quality.

[0025] 2. The bombardment effect and oxidation effect of active particles mediated by dielectric barrier discharge plasma equipment can quickly break protein peptide chains and generate small molecule peptides compared to traditional acid hydrolysis, thereby allowing protein fibers to quickly aggregate into fibers. Compared with traditional acid hydrolysis, it can effectively shorten the hysteresis period of protein hydrolysis into polypeptides during protein fiber formation, greatly shortening the protein fiber formation time. This technology shortens protein fiber formation from 24-48 hours in traditional acid-heat method to less than 6 hours.

[0026] 3. The dielectric barrier discharge plasma equipment is simple and easy to operate. After the protein CP treatment (0-10min), the protein fiber formation rate can reach 30% after heating for 30min, and the protein fiber formation rate can reach more than 70% after heating for 4h. There is no additive in the process, and it has the advantages of high efficiency and no chemical reagent residue. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 It is a structural diagram of the equipment used in the dielectric barrier discharge plasma treatment in the present invention.

[0028] Figure 2 The atomic force microscope images of the ovalbumin fibers of the embodiments of the present invention and the comparative examples are shown.

[0029] Figure 3 The atomic force microscope images of the ovalbumin fibers of the embodiments of the present invention and the comparative examples are shown.

[0030] Figure 4 The particle size distribution diagram of the ovalbumin fibers of the embodiments of the present invention and the comparative examples is shown in FIG. DETAILED DESCRIPTION

[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0032] See also Figure 1-Figure 4 , a method for preparing amyloid protein fibers using low-temperature plasma, comprising the following steps:

[0033] Step 1, weighing protein powder, dispersing it in deionized water, and stirring to fully disperse it to obtain a protein aqueous solution;

[0034] Among them, the concentration of the protein aqueous solution in the above steps is 2 to 100 mg / mL, the stirring speed is 30 to 1600 rpm, and the hydration time of the protein aqueous solution is 1 to 300 min. This step helps to dissolve the protein and form a uniform protein aqueous solution. The dispersed protein aqueous solution is easier to operate and further process, which can ensure the uniform distribution of the protein in the solution and avoid the formation of lumps or precipitation, which is beneficial to the stability and consistency of subsequent steps.

[0035] Step 2, treating the protein aqueous solution obtained in step 1 by a dielectric barrier discharge plasma device;

[0036] The dielectric barrier discharge plasma equipment used in the above step 2 is composed of a plasma power supply system, a transformer and a processing system, wherein the power supply system processes a voltage of 10 to 50 kV, a frequency of 0.5 to 5 kHz, and a processing time of 0 to 20 min. The processing system uses a quartz plate as an insulating medium, the spacing between electrodes is 0 to 10 mm, the sample container is a quartz dish, and the working gas is one or more of air, nitrogen, argon or helium. The processing process is: a certain amount of sample is placed in the quartz dish, the spacing between the two electrodes is adjusted to 8 mm, the insulating medium plate is fixed to the upper electrode, and air is used as the ionization medium.

[0037] Among them, the parameters of the quartz dish are φ40~60mm and the height is 3~8mm. The purpose of this step is to use high-energy active particles (such as atomic oxygen, hydroxyl free radicals, etc.) to treat the protein aqueous solution. The high-energy active particles can break the peptide bonds in the protein through bombardment, thereby forming shorter polypeptide chains. The active particles can also cause chemical modifications of protein molecules, such as oxidation, hydroxylation, etc., to change their chemical properties and functions. The polypeptide chains in the treated protein solution are easier to form fiber structures in subsequent steps, and form stable fibers through interaction and cross-linking.

[0038] Step 3, heating the protein aqueous solution after the treatment in step 2 in a water bath, and immediately placing it in an ice water bath after the heating is completed to terminate the reaction;

[0039] In the above steps, the water bath heating temperature is 50-100°C, and the water bath heating time is 0-72h. The role of this step is that heating can provide energy, promote the interaction between protein molecules, and accelerate the formation and growth of fibers. The appropriate temperature can enhance the mobility and flexibility of the polypeptide chain, which is conducive to the formation of a stable three-dimensional structure. Immediately after the water bath heating treatment, an ice water bath is used to stop the reaction, which can quickly cool the solution, fix the formed polypeptide chain structure and fiber morphology, and prevent unstable changes caused by excessive heating. By controlling the heating temperature and time, the properties of the final fiber, such as strength, thickness and transparency, can be adjusted. In addition, appropriate heating and cooling processes can help clean the production process and prevent protein colloids from depositing and clogging in the equipment.

[0040] Step 4: freeze-drying to obtain amyloid fibrils.

[0041] The freeze-drying time in the above steps is 8 to 72 hours. The function of this step is that freeze-drying can directly convert the water in the solution into gas at low temperature without changing the protein structure, which helps to maintain the original structure and morphological stability of the fiber. The freeze-drying process can effectively remove water and reduce the impact of water on the fiber structure and quality, thereby extending the shelf life of the fiber. At the same time, the freeze-drying process can make the protein fiber form a porous structure, which is beneficial to the subsequent dissolution and application in the solution, and improves the solubility and operability of the fiber.

[0042] The present invention is further described in detail below with reference to ovalbumin (OVA) as an implementation case:

[0043] Detection of OVA amyloid fibers in the present invention

[0044] (1) ThT fluorescent probe method

[0045] ThT is a dye that specifically stains β-folds in amyloid fibers. Use a fluorescence spectrometer to obtain the ThT fluorescence spectra of protein fiber solutions heated under different conditions. 8 mg of ThT was added to 10 mL of phosphate buffer (10 mM, pH = 7.0, 150 mM NaCl) to prepare a ThT stock solution. Then the ThT stock solution was diluted 50 times. 4 mL of the diluted ThT stock solution was mixed with 40 μL of the protein fiber solution, with an excitation wavelength of 440 nm and an emission wavelength of 480 nm. The fluorescence spectrum was measured and the maximum ThT fluorescence intensity of the protein fiber sample was recorded.

[0046] (2) Atomic force microscopy

[0047] To measure the morphological changes of amyloid OVA fibers, the sample was diluted with distilled water to obtain a protein concentration of 5ug / mL, 10uL of the protein dilution was pipetted onto the flat surface of the mica sheet, and placed in a fume hood at room temperature for 6 hours to air dry until it reached a dry state. The sample was scanned using the tapping mode, with a scanning rate of 1Hz, and 256 height curves (16×16 matrix) were obtained in a 2um scanning area.

[0048] (3) Dynamic light scattering (DLS)

[0049] The sample was diluted with distilled water to obtain a protein concentration of 1 mg / mL. The average particle size and particle size distribution of the sample were measured using a nanoparticle size analyzer at 25°C. Each sample was repeated three times.

[0050] Example 1

[0051] OVA solution (1%, w / v) was prepared by mixing egg white protein powder with distilled water (pH=7). 5 mL of sample was taken into a quartz dish, and the quartz dish was placed between two electrodes. The electrode distance was adjusted to 8 mm. The sample was treated for 2 min at a voltage of 40 kV and a frequency of 1.3±1 kHz. After the treatment, the sample was placed in an 85°C water bath for heating reaction for 0 to 8 h. Then, it was cooled in an ice water bath to obtain OVA amyloid fibers, which were stored at 4°C for further analysis.

[0052] Example 2

[0053] OVA solution (2%, w / v) was prepared by mixing egg white protein powder with distilled water (pH=7). 5 mL of sample was taken into a quartz dish, and the quartz dish was placed between two electrodes. The electrode distance was adjusted to 8 mm. The sample was treated for 4 min at a voltage of 40 kV and a frequency of 1.3±1 kHz. After the treatment, the sample was placed in a 90°C water bath for heating reaction for 0 to 8 h. Then, it was cooled in an ice water bath to obtain OVA amyloid fibers, which were stored at 4°C for further analysis.

[0054] Example 3

[0055] OVA solution (3%, w / v) was prepared by mixing egg white protein powder with distilled water (pH=7). 5 mL of sample was taken into a quartz dish, and the quartz dish was placed between two electrodes. The electrode distance was adjusted to 8 mm. The sample was treated for 6 min at a voltage of 40 kV and a frequency of 1.3±1 kHz. After the treatment, the sample was placed in a 95°C water bath for heating reaction for 0 to 8 h. Then, it was cooled in an ice water bath to obtain OVA amyloid fibers, which were stored at 4°C for further analysis.

[0056] Comparative Example 1

[0057] OVA powder was mixed with distilled water (pH = 2) to prepare OVA solution (1%, w / v), and then hydrated in a 4°C refrigerator overnight. The sample was placed in an 85°C water bath for heating reaction for 0 to 8 h. The fibril solution was immediately cooled to room temperature and stored at 4°C for further analysis.

[0058] The length and width of the OVA amyloid fibers obtained in Examples 1 to 3 and Comparative Example 1 were measured by AFM after heating for 8 hours. The measurement results are shown in Table 1.

[0059] Table 1 AFM protein morphology determination

[0060] serial number Fiber length (nm) Fiber width (nm) Example 1 358 3.4 Example 2 517 4.8 Example 3 680 5.6 Comparative Example 1 231 2

[0061] It can be seen from the results in Table 1 that the OVA protein fibers prepared in Examples 1 to 3 of the method of the present invention have significantly higher length and width than those in Comparative Example 1, and CP synergistic heating has obvious advantages in protein fiber formation.

[0062] In addition, the ThT fluorescence intensity of the samples of Examples 1 to 3 and Comparative Example 1 was measured. Figure 2 As shown, it can be seen that the fluorescence intensity of CP-modified ovalbumin fibers increases rapidly at the beginning of heating, and the increase is much higher than that of the acid-heat control group, proving that CP synergistic heat treatment can significantly increase fiber yield.

[0063] Figure 3 The results of atomic force microscopy showed that as the heating time increased, worm-like fibers were generated in both Example 1 and Comparative Example 1, and the fibers formed in Example 1 were thicker and longer in morphology than those generated by traditional acid-heat treatment, proving that the method adopted in the present invention has the effect of inducing protein aggregation into fibers, and the time for preparing mature fibers is shorter, the fiber length is longer, and the diameter is thicker.

[0064] For the proteins of Example 1 and Comparative Example 1, the particle size changes during the heating process are shown in FIG. Figure 4 When the heating time was extended to 8 h, the particle size of the protein fibers continued to increase, proving the growth and elongation of the fibrils. Compared with Comparative Example 1, the method adopted by the present invention induced protein aggregation to form fibers with larger particle size.

[0065] It can be seen from the above experimental results that the low-temperature plasma method proposed in the present invention has an excellent effect in preparing amyloid protein fibers.

[0066] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for preparing amyloid protein fibers using low-temperature plasma, characterized in that: The following steps are involved: Step 1, weighing protein powder, dispersing it in deionized water, and stirring to fully disperse it to obtain a protein aqueous solution; Step 2, treating the protein aqueous solution obtained in step 1 by a dielectric barrier discharge plasma device; Step 3, heating the protein aqueous solution after the treatment in step 2 in a water bath, and immediately placing it in an ice water bath after the heating is completed to terminate the reaction; Step 4: freeze-drying to obtain amyloid fibrils.

2. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 1, characterized in that: The protein powder in step 1 is one or more of ovalbumin, pea protein isolate, whey protein, β-lactoglobulin and soy protein isolate.

3. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 1, characterized in that: The concentration of the protein aqueous solution in step 1 is 2-100 mg / mL.

4. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 3, characterized in that: In the step 1, the stirring speed is 30 to 1600 rpm, and the hydration time of the protein aqueous solution is 1 to 300 min.

5. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 1, characterized in that: The dielectric barrier discharge plasma equipment in step 2 is composed of a plasma power system, a transformer, a processing system and a sample container. The processing voltage of the plasma power system is 10 to 50 kV and the frequency is 0.5 to 5 kHz. The processing system uses a quartz sheet as an insulating medium, and the distance between electrodes is 0 to 10 mm. The sample container is a quartz dish, and the working gas of the dielectric barrier discharge plasma equipment is one or more of air, nitrogen, argon or helium.

6. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 5, characterized in that: The parameters of the quartz dish are φ40-60mm and the height is 3-8mm.

7. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 5, characterized in that: The dielectric barrier discharge plasma equipment treatment time in step 2 is 0 to 20 minutes.

8. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 1, characterized in that: The temperature of the water bath heating treatment in step 3 is 50-100°C.

9. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 8, characterized in that: The time of water bath heating treatment in step 3 is 0 to 72 hours.

10. The method for preparing amyloid protein fibers using low-temperature plasma according to claim 1, characterized in that: The freeze-drying time in step 4 is 8 to 72 hours.

Citation Information

Cited By

  • Special medical purpose formula food for liver diseases and preparation method of special medical purpose formula food

    CN119214299A

  • Method for preparing homogeneous amyloid fiber

    CN119465428A